Pulse Explore Journal Club Debates Trending Researchers

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

Role of IL-6 and IL-6 targeted therapy in systemic lupus erythematosus | Synapse

August 18, 2023

View Full Paper

Role of IL-6 and IL-6 targeted therapy in systemic lupus erythematosus

DNDesh NepalMedical College of Wisconsin DGDavid GazeleyMedical College of Wisconsin

Key Points

Key points are not available for this paper at this time.

Abstract

Interleukin-6 (IL-6) is one of the cytokines implicated in murine and human SLE. Only a few small studies have investigated IL-6 inhibition in human SLE. Currently, there are no studies registered in clinicaltrials.gov to assess the IL-6 targeted therapy in SLE, yet its role in the future remains to be defined. This narrative review analyses these and potential areas of future studies with IL-6 targeted therapy in SLE.

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Nepal et al. (Fri,) studied this question.

synapsesocial.com/papers/69d88e1b8cb8f39931ae336c https://doi.org/https://doi.org/10.1093/rheumatology/kead416

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses2019 · 207 citations
2Tocilizumab in rheumatoid arthritis: A meta-analysis of efficacy and selected clinical conundrums2013 · 98 citations
3The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells2009 · 440 citations
4Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis2020 · 989 citations
5Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies2021 · 92 citations